Informed-money record
EDSA · Edesa Biotech, Inc.
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
9
Bearish filings
0
Named actors
2
Disclosed $ (bull / bear)
$233K / $0
Recent disclosures
9 of 9 in the window · linked to source| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-03-10 | Chief Executive Officer Nijhawan Pardeep | bought | $7K | SEC ↗ |
| 2026-03-05 | Chief Executive Officer Nijhawan Pardeep | bought | $39K | SEC ↗ |
| 2026-03-04 | Chief Executive Officer Nijhawan Pardeep | bought | $43K | SEC ↗ |
| 2026-03-03 | Chief Executive Officer Nijhawan Pardeep | bought | $36K | SEC ↗ |
| 2026-03-02 | Chief Executive Officer Nijhawan Pardeep | bought | $4K | SEC ↗ |
| 2026-03-02 | Chief Executive Officer Nijhawan Pardeep | bought | $2K | SEC ↗ |
| 2026-02-27 | Chief Executive Officer Nijhawan Pardeep | bought | $67K | SEC ↗ |
| 2026-02-26 | Chief Executive Officer Nijhawan Pardeep | bought | $33K | SEC ↗ |
| 2026-02-26 | President Brooks Michael J | bought | $3K | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Dispute or correct this record
Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals